Insecticides India Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/q8s8ifl2180ihu22r61ssghm.pdf

Key Takeaways


Volume vs Value: The Low-Rain Tradeoff

Rajesh Aggarwal: "This is not a year of volume growth. We'll just end up doing the value growth because the volume has already suffered because of low rains."

Kaeros: The Parallel Brand Bet

Rajesh Aggarwal: "Next year, we can very well plan to double from here."

Capex Endgame & Manufacturing Scale-Up

Rajesh Aggarwal: "After completion of Sotanala project, major capex cycle will be left behind us."

International & CDMO: The Five-Year Bet

Rajesh Aggarwal: "I wish to grow at a CAGR of not less than 40%, 50% because my base is very small. So let's see how the things progress. But I can say that 5 years down the line, I see my business as INR500 crores from international markets..."

Product Pipeline & R&D Philosophy

Rajesh Aggarwal: "I believe that R&D is to perform and not to show. So we believe in performance. With lower expenses, we wish to do more R&D."

Margins, Working Capital & Returns

Rajesh Aggarwal: "I'm very, very confident that we'll not only grow our top line, we'll grow the bottom line margins also in terms of percentage and in terms of actual numbers."

Guidance & Commitments

CommitmentSpecificsTimeline
Dahej plant completionPlant to be fully completed and restarted in full swingDecember (Q3 FY27)
Sotanala formulation startFormulation business to begin operationsApril, possible delay to May
Sotanala technical manufacturing startTechnical manufacturing to commenceNext fiscal; vision Diwali, fallback December/January
Major capex cycle endMajor capex cycle left behind after Sotanala completionNext fiscal
Kaeros all-India networkSouthern markets opened, making Kaeros visible across IndiaH2 of this fiscal
Kaeros stand-alone turnover~₹200 crores stand-aloneThis fiscal
Kaeros brand turnoverCross ₹125 croresThis fiscal
Kaeros growth next yearDouble from this fiscal's level (100% CAGR possible)Next fiscal
Premium product contributionTouch 70% of portfolioNo date; target to be revised after achievement
International business 5-year target₹500 crores from international markets5 years
OAT Agrio first product launchFirst product from JV to hit marketNext fiscal (chance); 2027 target may slip by a few months
Gross margin long-term trajectory~1% annual improvement on average, step-by-step toward best-in-industryOngoing; some years 2–3% jump, some only bps
Nissan new herbicide launchNew mode-of-action herbicide launchedThis kharif season
CDMO scale-upBuild DCS plant at Sotanala, upgrade Dahej; target big wayNext fiscal

Key Metrics

MetricQ2 FY27
Revenue from operations₹686 cr, 8% YoY growth vs ₹637 cr in Q2 FY26
H1 FY27 revenue growth2% degrowth YoY
Gross profit margin33.7%, vs 34.5% in Q2 FY26
EBITDA₹92.44 cr; EBITDA margin 13.5%
Profit after tax₹56.17 cr
H1 FY27 gross profit margin32.7%, ~100 bps improvement vs 31.7% in H1 FY26
H1 FY27 EBITDA₹161 cr; EBITDA margin 12.3%
H1 FY27 profit after tax~₹100 cr
Volume growthNegative, drop of about 6% to 7% YoY
Value growth4% to 5% YoY
Working capital days158 days in H1 FY27, vs 151 days in H1 FY26
Net working capital~₹1,000 cr as of 30 Sep, vs ₹966 cr as of 30 Sep '25 and ₹828 cr as of 31 Mar '26
Inventory₹814 cr as of 30 Sep, vs ₹744 cr
Debtors₹719 cr as of 30 Sep, vs ₹643 cr
Kaeros total sales H1 FY27~₹114 cr; brand gross turnover ~₹75 cr
Kaeros full-year brand turnover targetCross ₹125 cr; stand-alone might touch ~₹200 cr
Premium products contribution60%+ of B2C portfolio; target to touch 70%
International business contribution~5% of revenue
B2B business~₹400 cr+
Farmer meetings in H1More than 18,000
Demonstrations in H1More than 9,000
Farmers met in H1More than 2.5 lakh
ICS plots~70 across 4 crops, doubled from ~30 last year
R&D expense booked~₹12 cr annually